Shape Therapeutics

About Shape Therapeutics

ShapeTX is a biotechnology company utilizing AI to design programmable RNA medicines that reprogram cellular functions to address genetic disorders. Their RNAfix technology corrects mutations by recoding RNA without altering DNA, enabling precise treatment for a wide range of diseases.

ShapeTX is a biotechnology company utilizing AI to design programmable RNA medicines that reprogram cellular functions to address genetic disorders. Their RNAfix technology corrects mutations by recoding RNA without altering DNA, enabling precise treatment for a wide range of diseases.

What does Shape Therapeutics do?

ShapeTX is a biotechnology company utilizing AI to design programmable RNA medicines that reprogram cellular functions to address genetic disorders. Their RNAfix technology corrects mutations by recoding RNA without altering DNA, enabling precise treatment for a wide range of diseases.

Where is Shape Therapeutics located?

Shape Therapeutics is based in Seattle, United States.

When was Shape Therapeutics founded?

Shape Therapeutics was founded in 2018.

How much funding has Shape Therapeutics raised?

Shape Therapeutics has raised 147500000.

Location
Seattle, United States
Founded
2018
Funding
147500000
Employees
137 employees
Major Investors
Breton Capital Management, Decheng Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

Shape Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

ShapeTX is a biotechnology company utilizing AI to design programmable RNA medicines that reprogram cellular functions to address genetic disorders. Their RNAfix technology corrects mutations by recoding RNA without altering DNA, enabling precise treatment for a wide range of diseases.

shapetx.com10K+
cb
Crunchbase
Founded 2018Seattle, United States

Funding

$

Estimated Funding

$100M+

Major Investors

Breton Capital Management, Decheng Capital

Team (100+)

No team information available.

Company Description

ShapeTX is a biotechnology company utilizing AI to design programmable RNA medicines that reprogram cellular functions to address genetic disorders. Their RNAfix technology corrects mutations by recoding RNA without altering DNA, enabling precise treatment for a wide range of diseases.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.